NO144071C - Analogifremgangsmaate ved fremstilling av antihypertensivt aktive thienyl- og thietyl-ureaer - Google Patents

Analogifremgangsmaate ved fremstilling av antihypertensivt aktive thienyl- og thietyl-ureaer

Info

Publication number: NO144071C
Authority: NO; Norway
Prior art keywords: thietyl; urea; preparation; analogy procedure; antihypertensive active
Prior art date: 1974-04-17

Application number

NO751351A

Other languages

English (en)

Other versions

NO144071B (no

NO751351L (no

Inventor

Paul Edward Aldrich

Gilbert Harvey Berezin

Bruce Ivor Dittmar

Original Assignee

Du Pont

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1974-04-17

Filing date

1975-04-16

Publication date

1981-06-17

1975-04-16 Application filed by Du Pont filed Critical Du Pont

1975-10-20 Publication of NO751351L publication Critical patent/NO751351L/no

1981-03-09 Publication of NO144071B publication Critical patent/NO144071B/no

1981-06-17 Publication of NO144071C publication Critical patent/NO144071C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
- C07D331/04—Four-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
- C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO751351A 1974-04-17 1975-04-16 Analogifremgangsmaate ved fremstilling av antihypertensivt aktive thienyl- og thietyl-ureaer NO144071C (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US46169974A	1974-04-17	1974-04-17
US05/555,307 US4009847A (en)	1974-04-17	1975-03-11	1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Publications (3)

Publication Number	Publication Date
NO751351L NO751351L (no)	1975-10-20
NO144071B NO144071B (no)	1981-03-09
NO144071C true NO144071C (no)	1981-06-17

Family

ID=27040095

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO751351A NO144071C (no)	1974-04-17	1975-04-16	Analogifremgangsmaate ved fremstilling av antihypertensivt aktive thienyl- og thietyl-ureaer

Country Status (21)

Country	Link
US (1)	US4009847A (no)
JP (1)	JPS50148349A (no)
AR (1)	AR208545A1 (no)
CA (1)	CA1047042A (no)
CH (1)	CH611292A5 (no)
DD (1)	DD117223A5 (no)
DE (1)	DE2516554A1 (no)
DK (1)	DK164175A (no)
ES (1)	ES436648A1 (no)
FI (1)	FI751128A (no)
FR (1)	FR2267773B1 (no)
GB (1)	GB1461209A (no)
HU (1)	HU173052B (no)
IE (1)	IE41143B1 (no)
IL (1)	IL47095A (no)
LU (1)	LU72306A1 (no)
NL (1)	NL7504570A (no)
NO (1)	NO144071C (no)
PH (1)	PH11722A (no)
SE (1)	SE417965B (no)
YU (1)	YU96075A (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4156738A (en) *	1977-10-07	1979-05-29	E. I. Du Pont De Nemours And Company	Ureidonitriles useful as antihypertensives
US6344476B1 (en)	1997-05-23	2002-02-05	Bayer Corporation	Inhibition of p38 kinase activity by aryl ureas
US6187799B1 (en) *	1997-05-23	2001-02-13	Onyx Pharmaceuticals	Inhibition of raf kinase activity using aryl ureas
US20080300281A1 (en) *	1997-12-22	2008-12-04	Jacques Dumas	Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US7329670B1 (en)	1997-12-22	2008-02-12	Bayer Pharmaceuticals Corporation	Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US7517880B2 (en)	1997-12-22	2009-04-14	Bayer Pharmaceuticals Corporation	Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US20080269265A1 (en) *	1998-12-22	2008-10-30	Scott Miller	Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
WO2000042012A1 (en)	1999-01-13	2000-07-20	Bayer Corporation	φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
US8124630B2 (en) *	1999-01-13	2012-02-28	Bayer Healthcare Llc	ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ATE556713T1 (de) *	1999-01-13	2012-05-15	Bayer Healthcare Llc	Omega-carboxyarylsubstituierte-diphenyl- harnstoffe als p38-kinasehemmer
US7928239B2 (en)	1999-01-13	2011-04-19	Bayer Healthcare Llc	Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
ME00275B (me) *	1999-01-13	2011-02-10	Bayer Corp	ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
US7235576B1 (en)	2001-01-12	2007-06-26	Bayer Pharmaceuticals Corporation	Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) *	2001-04-20	2008-05-13	Bayer Pharmaceuticals Corporation	Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
MXPA04005137A (es) *	2001-12-03	2005-06-03	Bayer Pharmaceuticals Corp	Compuestos de aril urea en combinacion con otros agentes citostaticos para el tratamiento de canceres humanos.
US20080108672A1 (en) *	2002-01-11	2008-05-08	Bernd Riedl	Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
CN1318404C (zh)	2002-02-11	2007-05-30	拜耳制药公司	作为激酶抑制剂的芳基脲类化合物
EP1478358B1 (en) *	2002-02-11	2013-07-03	Bayer HealthCare LLC	Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis
AU2003209119A1 (en) *	2002-02-11	2003-09-04	Bayer Pharmaceuticals Corporation	Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
WO2003068223A1 (en) *	2002-02-11	2003-08-21	Bayer Corporation	Aryl ureas with raf kinase and angiogenesis inhibiting activity
US7557129B2 (en)	2003-02-28	2009-07-07	Bayer Healthcare Llc	Cyanopyridine derivatives useful in the treatment of cancer and other disorders
DK1626714T3 (da) *	2003-05-20	2007-10-15	Bayer Pharmaceuticals Corp	Dirarylurinstoffer mod sygdomme medieret af PDGFR
UA84156C2 (ru) *	2003-07-23	2008-09-25	Байер Фармасьютикалс Корпорейшн	Фторозамещённая омега-карбоксиарилдифенилмочевина для лечения и профилактики болезней и состояний
US7838524B2 (en) *	2004-04-30	2010-11-23	Bayer Healthcare Llc	Substituted pyrazolyl urea derivatives useful in the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH452475A (de) *	1965-05-20	1968-05-31	Bayer Ag	Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen

1975
- 1975-03-11 US US05/555,307 patent/US4009847A/en not_active Expired - Lifetime
- 1975-03-26 SE SE7503523A patent/SE417965B/xx unknown
- 1975-04-15 IL IL47095A patent/IL47095A/xx unknown
- 1975-04-15 CA CA224,634A patent/CA1047042A/en not_active Expired
- 1975-04-16 HU HU75DU237A patent/HU173052B/hu unknown
- 1975-04-16 ES ES436648A patent/ES436648A1/es not_active Expired
- 1975-04-16 AR AR258396A patent/AR208545A1/es active
- 1975-04-16 DE DE19752516554 patent/DE2516554A1/de not_active Withdrawn
- 1975-04-16 FI FI751128A patent/FI751128A/fi not_active Application Discontinuation
- 1975-04-16 GB GB1567175A patent/GB1461209A/en not_active Expired
- 1975-04-16 YU YU00960/75A patent/YU96075A/xx unknown
- 1975-04-16 DK DK164175A patent/DK164175A/da not_active IP Right Cessation
- 1975-04-16 DD DD185482A patent/DD117223A5/xx unknown
- 1975-04-16 NO NO751351A patent/NO144071C/no unknown
- 1975-04-16 PH PH17061A patent/PH11722A/en unknown
- 1975-04-16 FR FR7511796A patent/FR2267773B1/fr not_active Expired
- 1975-04-17 JP JP50045924A patent/JPS50148349A/ja active Pending
- 1975-04-17 IE IE865/75A patent/IE41143B1/xx unknown
- 1975-04-17 CH CH494875A patent/CH611292A5/xx not_active IP Right Cessation
- 1975-04-17 NL NL7504570A patent/NL7504570A/xx not_active Application Discontinuation
- 1975-04-17 LU LU72306A patent/LU72306A1/xx unknown

Also Published As

Publication number	Publication date
LU72306A1 (no)	1976-03-17
CH611292A5 (no)	1979-05-31
SE417965B (sv)	1981-04-27
NL7504570A (nl)	1975-10-21
IE41143B1 (en)	1979-10-24
AU8013575A (en)	1976-10-21
ES436648A1 (es)	1977-08-01
FI751128A (no)	1975-10-18
AR208545A1 (es)	1977-02-15
DD117223A5 (no)	1976-01-05
PH11722A (en)	1978-05-30
IL47095A0 (en)	1975-06-25
NO144071B (no)	1981-03-09
IE41143L (en)	1975-10-17
FR2267773B1 (no)	1978-08-18
JPS50148349A (no)	1975-11-27
US4009847A (en)	1977-03-01
GB1461209A (en)	1977-01-13
FR2267773A1 (no)	1975-11-14
NO751351L (no)	1975-10-20
DK164175A (da)	1975-10-18
DE2516554A1 (de)	1975-10-30
IL47095A (en)	1978-03-10
HU173052B (hu)	1979-02-28
CA1047042A (en)	1979-01-23
SE7503523L (sv)	1975-10-20
YU96075A (en)	1983-04-27

Similar Documents

Publication	Publication Date	Title
NO144071C (no)	1981-06-17	Analogifremgangsmaate ved fremstilling av antihypertensivt aktive thienyl- og thietyl-ureaer
NO149106C (no)	1984-02-22	Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
NO142402C (no)	1980-08-13	Analogifremgangsmaate for fremstilling av farmakologisk aktive benzimidazoler
NO147243C (no)	1983-03-02	Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO143942C (no)	1981-05-13	Analogifremgangsmaate for fremstilling av farmakologisk aktive heterocyklisk substituerte guanidiner
NO141800C (no)	1980-06-04	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO143460C (no)	1981-02-18	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO151411C (no)	1985-04-10	Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO147109C (no)	1983-02-02	Analogifremgangsmaate ved fremstilling av terapeutisk aktive diazepin-derivater
NO143315C (no)	1981-01-14	Analogifremgangsmaate ved fremstilling av farmakologisk aktive bis-imidazol-derivater
NO146096C (no)	1982-07-28	Analogifremgangsmaate ved fremstilling av thienothiazinderivater
SE423996B (sv)	1982-06-21	Forfarande for framstellning av daunomycin- och adriamycin-derivat
NO142838C (no)	1980-10-29	Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
SE421209B (sv)	1981-12-07	Analogiforfarande for framstellning av tienobensodiazepiner
NO141894C (no)	1980-06-04	Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
NO143381C (no)	1981-01-28	Analogifremgangsmaate ved fremstilling av farmakologisk aktive guanidin- og isotioureaderivater
NO144108C (no)	1981-06-24	Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider
NO143625C (no)	1981-03-18	Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
NO148488C (no)	1983-10-19	Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO147485C (no)	1983-04-20	Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater
NO145238C (no)	1982-02-10	Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater
SE417596B (sv)	1981-03-30	Forfarande for framstellning av fast ammoniumfosfat
NO146672C (no)	1982-11-17	Analogifremgangsmaate for fremstilling av terapeutisk aktive cinnolinderivater
NO142403C (no)	1980-08-13	Analogifremgangsmaate for fremstilling av farmakologisk aktive isokinoliner.
SE414029B (sv)	1980-07-07	Forfarande for framstellning av terapeutiskt aktiva fentiazinderivat